Evaluation of anti-methicillin-resistant Staphylococcus aureus property of zerumbone.

IF 2 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Journal of applied biomedicine Pub Date : 2022-02-11 DOI:10.32725/jab.2022.002
Shaymaa Fadhel Abbas Albaayit, Rukesh Maharjan, Rasedee Abdullah, Mohd Hezmee Mohd Noor
{"title":"Evaluation of anti-methicillin-resistant Staphylococcus aureus property of zerumbone.","authors":"Shaymaa Fadhel Abbas Albaayit, Rukesh Maharjan, Rasedee Abdullah, Mohd Hezmee Mohd Noor","doi":"10.32725/jab.2022.002","DOIUrl":null,"url":null,"abstract":"<p><strong>Context and objective: </strong>Zerumbone has been reported to exert anti-microbial effects, but the mechanism by which the compound exerts its action is not known. Thus, this study aimed to investigate the mechanism of action of zerumbone against methicillin-resistance Staphylococcus aureus (MRSA), using the atomic force microscopy (AFM), scanning electron microscopy (SEM), and flow cytometry techniques.</p><p><strong>Methods: </strong>MRSA (NCTC 13277) cell viability was determined using the microplate AlamarBlue assay. AFM and SEM were used to determine the morphology of zerumbone-treated MRSA cells. Flow cytometric analysis was used to determine the effect of zerumbone on bacterial membrane permeability and membrane potential, using the propidium iodide (PI) staining method, membrane potential-sensitive fluorescence probe, and DiBAC4(3) dye. DCFDA dye was used to determine the generation of reactive oxygen species (ROS) by MRSA.</p><p><strong>Results: </strong>Zerumbone significantly inhibited MRSA growth with a minimum inhibitory concentration (MIC) of 125 µg/ml. The AFM analysis showed that zerumbone caused leakage of cytoplasmic content from the bacterial cells. Ultrastructure analysis showed small colonies of the bacteria with pores on the membrane surface. There were increases in zerumbone-treated MRSA PI and DiBAC4(3) fluorescence, indicating an increase in cell membrane permeability and a decrease in membrane potential that culminated in the loss of membrane structural integrity and bacterial death. Based on DCFDA dye analysis, zerumbone also reduced ROS production by MRSA.</p><p><strong>Conclusions: </strong>Zerumbone exerts anti-MRSA effects by causing membrane depolarization, increasing membrane permeability, and finally disrupting cell membrane and bacterial killing.</p>","PeriodicalId":14912,"journal":{"name":"Journal of applied biomedicine","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2022-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of applied biomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.32725/jab.2022.002","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Context and objective: Zerumbone has been reported to exert anti-microbial effects, but the mechanism by which the compound exerts its action is not known. Thus, this study aimed to investigate the mechanism of action of zerumbone against methicillin-resistance Staphylococcus aureus (MRSA), using the atomic force microscopy (AFM), scanning electron microscopy (SEM), and flow cytometry techniques.

Methods: MRSA (NCTC 13277) cell viability was determined using the microplate AlamarBlue assay. AFM and SEM were used to determine the morphology of zerumbone-treated MRSA cells. Flow cytometric analysis was used to determine the effect of zerumbone on bacterial membrane permeability and membrane potential, using the propidium iodide (PI) staining method, membrane potential-sensitive fluorescence probe, and DiBAC4(3) dye. DCFDA dye was used to determine the generation of reactive oxygen species (ROS) by MRSA.

Results: Zerumbone significantly inhibited MRSA growth with a minimum inhibitory concentration (MIC) of 125 µg/ml. The AFM analysis showed that zerumbone caused leakage of cytoplasmic content from the bacterial cells. Ultrastructure analysis showed small colonies of the bacteria with pores on the membrane surface. There were increases in zerumbone-treated MRSA PI and DiBAC4(3) fluorescence, indicating an increase in cell membrane permeability and a decrease in membrane potential that culminated in the loss of membrane structural integrity and bacterial death. Based on DCFDA dye analysis, zerumbone also reduced ROS production by MRSA.

Conclusions: Zerumbone exerts anti-MRSA effects by causing membrane depolarization, increasing membrane permeability, and finally disrupting cell membrane and bacterial killing.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估泽润邦抗耐甲氧西林金黄色葡萄球菌的特性
背景和目的:据报道,折仑巴酮具有抗微生物作用,但该化合物的作用机制尚不清楚。因此,本研究旨在利用原子力显微镜(AFM)、扫描电子显微镜(SEM)和流式细胞仪技术,研究折仑波酮对耐甲氧西林金黄色葡萄球菌(MRSA)的作用机制:方法:使用微孔板 AlamarBlue 检测法测定 MRSA(NCTC 13277)细胞的活力。原子力显微镜(AFM)和扫描电子显微镜(SEM)用于确定经泽润邦处理的 MRSA 细胞的形态。使用碘化丙啶(PI)染色法、膜电位敏感荧光探针和 DiBAC4(3) 染料进行流式细胞分析,以确定折仑邦对细菌膜通透性和膜电位的影响。DCFDA染料用于测定MRSA产生的活性氧(ROS):结果:折仑波能明显抑制 MRSA 的生长,最低抑制浓度为 125 µg/ml。原子力显微镜(AFM)分析表明,泽润邦会导致细菌细胞中的细胞质成分泄漏。超微结构分析表明,细菌的小菌落膜表面有孔。经泽伦邦处理的 MRSA PI 和 DiBAC4(3) 荧光增加,表明细胞膜通透性增加,膜电位降低,最终导致膜结构完整性丧失和细菌死亡。根据 DCFDA 染料分析,泽润邦还能减少 MRSA 产生的 ROS:结论:泽润邦通过引起膜去极化、增加膜通透性、最终破坏细胞膜并杀死细菌来发挥抗 MRSA 的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of applied biomedicine
Journal of applied biomedicine PHARMACOLOGY & PHARMACY-
CiteScore
2.40
自引率
7.70%
发文量
13
审稿时长
>12 weeks
期刊介绍: Journal of Applied Biomedicine promotes translation of basic biomedical research into clinical investigation, conversion of clinical evidence into practice in all medical fields, and publication of new ideas for conquering human health problems across disciplines. Providing a unique perspective, this international journal publishes peer-reviewed original papers and reviews offering a sensible transfer of basic research to applied clinical medicine. Journal of Applied Biomedicine covers the latest developments in various fields of biomedicine with special attention to cardiology and cardiovascular diseases, genetics, immunology, environmental health, toxicology, neurology and oncology as well as multidisciplinary studies. The views of experts on current advances in nanotechnology and molecular/cell biology will be also considered for publication as long as they have a direct clinical impact on human health. The journal does not accept basic science research or research without significant clinical implications. Manuscripts with innovative ideas and approaches that bridge different fields and show clear perspectives for clinical applications are considered with top priority.
期刊最新文献
Anti-NMDAR1 antibody impairs dendritic branching in immature cultured neurons. Astragaloside IV confronts amyloid-beta-induced astrocyte senescence via hsp90aa1. In vitro biological activities of Calamintha nepeta L. aqueous extracts. Olfactory event-related potentials (OERPs) and trigeminal event-related potentials (TERPs) in subjects after Covid-19 infection: single-center prospective study. Salivary glands - a new site of Helicobacter pylori occurrence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1